Presented by
Jen Koevary
Nominated by
The University of Arizona
MyCardia™ has the potential to improve heart function and quality of life in patients with heart failure. The heart lacks regenerative capabilities. As a consequence, injuries to the heart such as myocardial infarction (heart attack) place a massive burden on the ability of the heart to perform (contract and relax) properly. MyCardia™ has been shown to improve both the squeeze and relaxation of the heart which can improve how well the patient feels and increase their quality of life.